FR2296423A1 - Nouveaux acides d 2,3-1,4-morpholino - Google Patents

Nouveaux acides d 2,3-1,4-morpholino

Info

Publication number
FR2296423A1
FR2296423A1 FR7540370A FR7540370A FR2296423A1 FR 2296423 A1 FR2296423 A1 FR 2296423A1 FR 7540370 A FR7540370 A FR 7540370A FR 7540370 A FR7540370 A FR 7540370A FR 2296423 A1 FR2296423 A1 FR 2296423A1
Authority
FR
France
Prior art keywords
morpholino
acids
new
morpholino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7540370A
Other languages
English (en)
Other versions
FR2296423B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Canada Inc
Original Assignee
Bristol Myers Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Canada Ltd filed Critical Bristol Myers Canada Ltd
Publication of FR2296423A1 publication Critical patent/FR2296423A1/fr
Application granted granted Critical
Publication of FR2296423B1 publication Critical patent/FR2296423B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cephalosporin Compounds (AREA)
FR7540370A 1975-01-02 1975-12-31 Nouveaux acides d 2,3-1,4-morpholino Granted FR2296423A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/538,271 US4012383A (en) 1975-01-02 1975-01-02 Δ2,3 -1,4-morpholine-2-carboxylic acids and derivatives thereof useful in preparation of antibacteria agents

Publications (2)

Publication Number Publication Date
FR2296423A1 true FR2296423A1 (fr) 1976-07-30
FR2296423B1 FR2296423B1 (fr) 1978-09-22

Family

ID=24146199

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7540370A Granted FR2296423A1 (fr) 1975-01-02 1975-12-31 Nouveaux acides d 2,3-1,4-morpholino

Country Status (7)

Country Link
US (4) US4012383A (fr)
JP (3) JPS613790B2 (fr)
BE (1) BE837265A (fr)
CA (2) CA1095041A (fr)
DE (1) DE2600039A1 (fr)
FR (1) FR2296423A1 (fr)
GB (1) GB1538240A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2372165A1 (fr) * 1976-09-08 1978-06-23 Smithkline Corp
EP0009671A2 (fr) * 1978-09-12 1980-04-16 Fujisawa Pharmaceutical Co., Ltd. Produits de départ pour la préparation de composés du type céphem et procédé pour leur préparation

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172199A (en) * 1975-01-02 1979-10-23 Bristol-Myers Company O-2-isocephem-4-carboxylic acid derivatives as antibacterial agents
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
US4171438A (en) * 1975-07-23 1979-10-16 Bristol-Myers Company 0-2-Isocephem-4-carboxylic acid derivatives as antibacterial agents
US4013648A (en) * 1975-07-23 1977-03-22 Bristol-Myers Company Δ2,3 -0-2-Isocephem-4-carboxylic acid and derivatives as antibacterial agents
AU516665B2 (en) * 1975-10-06 1981-06-18 Fujisawa Pharmaceutical Co., Ltd 2-azetidone compounds
US4162250A (en) * 1976-09-08 1979-07-24 Smithkline Corporation 3-Aminoazetidinone derivatives
FR2380221A1 (fr) * 1977-02-11 1978-09-08 Ugine Kuhlmann Perfectionnement au procede de preparation du percarbonate de sodium
JPH02111750A (ja) * 1978-09-12 1990-04-24 Fujisawa Pharmaceut Co Ltd 酪酸誘導体
EP0025602B1 (fr) * 1979-09-13 1984-12-19 Kyowa Hakko Kogyo Co., Ltd Analogues acylés de céphalosporine, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4663450A (en) * 1979-10-25 1987-05-05 Kyowa Hakko Kogyo Co., Ltd. Optically active cephalosporin analogs
FR2505840A1 (fr) * 1981-05-13 1982-11-19 Roussel Uclaf Nouveaux produits derives de l'acide 2-amino thiazolyl 2-oxyimino acetamido bicyclo-octene carboxylique, leur procede de preparation et leur application comme medicaments
JPS58192866A (ja) * 1982-04-30 1983-11-10 Kanegafuchi Chem Ind Co Ltd ２―アゼチジノン誘導体
CA1204746A (fr) * 1982-08-19 1986-05-20 Hoffmann-La Roche Limited Beta-lactams
JP2525170B2 (ja) * 1987-03-09 1996-08-14 大塚製薬株式会社 ２―オキサイソセフェム誘導体の製造方法
US8593825B2 (en) * 2009-10-14 2013-11-26 Wintec Industries, Inc. Apparatus and method for vertically-structured passive components
CN103508969A (zh) * 2013-09-09 2014-01-15 南通市华峰化工有限责任公司 一种高纯度5-四氮唑乙酸的合成生产方法
US20160251387A1 (en) * 2013-10-10 2016-09-01 Merck Patent Gmbh Synthesis of 1-alkyl-2-amino-imidazol-5-carboxylic acid ester via calpha-substituted n-alkyl-glycine ester derivatives
CN114345304A (zh) * 2021-12-30 2022-04-15 北京建工环境修复股份有限公司 一种负载零价铁的纤维素壳聚糖复合微球及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1914366A1 (de) * 1969-03-21 1970-10-01 Bayer Ag Arzneimittel auf Basis neuer,heterocyclischer Verbindungen
CH541577A (de) * 1970-11-03 1973-09-15 Ciba Geigy Ag Verfahren zur Herstellung thiaheterocyclischer Verbindungen
DE2219601A1 (de) 1971-04-27 1972-11-16 Astra Läkemedel AB, Södertälje (Schweden) beta-Lactame und Verfahren zu deren Herstellung
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US4011216A (en) * 1975-04-11 1977-03-08 Bristol-Myers Company Δ2,3-0-2-Isocephem-4-carboxylic acid and derivatives thereof as antibacterial agents
US4136648A (en) * 1976-12-22 1979-01-30 Ford Motor Company Low weight reciprocating engine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2372165A1 (fr) * 1976-09-08 1978-06-23 Smithkline Corp
FR2375239A1 (fr) * 1976-09-08 1978-07-21 Smithkline Corp Derives d'acide 7-amino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique
EP0009671A2 (fr) * 1978-09-12 1980-04-16 Fujisawa Pharmaceutical Co., Ltd. Produits de départ pour la préparation de composés du type céphem et procédé pour leur préparation
EP0009671A3 (en) * 1978-09-12 1980-06-25 Fujisawa Pharmaceutical Co. Ltd. Starting compounds for preparing cephem compounds, processes for their preparation, processes for preparing cephem compounds and cephems so obtained

Also Published As

Publication number Publication date
GB1538240A (en) 1979-01-17
CA1095041A (fr) 1981-02-03
BE837265A (fr) 1976-06-30
US4012383A (en) 1977-03-15
FR2296423B1 (fr) 1978-09-22
JPS6229435B2 (fr) 1987-06-25
JPS613790B2 (fr) 1986-02-04
JPS6229434B2 (fr) 1987-06-25
CA1109873A (fr) 1981-09-29
JPS61197586A (ja) 1986-09-01
JPS61197587A (ja) 1986-09-01
JPS5191293A (fr) 1976-08-10
US4065623A (en) 1977-12-27
US4066831A (en) 1978-01-03
DE2600039A1 (de) 1976-12-02
US4113946A (en) 1978-09-12

Similar Documents

Publication Publication Date Title
BE852738A (fr) Nouveaux acides acetohydroxamiques
BE820542A (fr) Nouveaux acides monoalkylamino-4-benzoiques
FR2296423A1 (fr) Nouveaux acides d 2,3-1,4-morpholino
FR2319646A1 (fr) Acides 1-hydroxy-3-aminoalcane-1,1-diphosphoniques
BE836835A (fr) Nouveaux acides amino cycliques
FR2300081A1 (fr) Nouveaux d
FR2316934A1 (fr) Acides 2,3-dihydro-6,7-disubstitue-5-(acyl)benzofuran-2-carboxyliques
BE822345A (fr) Nouveaux 1
FR2321276A1 (fr) Derives d'acides phenoxy-alkylcarboxyliques
FR2301246A1 (fr) Acides 6-oxo 7,7-disubstitues-6h-indeno
BE820013A (fr) Acides carboxyphenyl-alkyphosphiniques
FR2309562A1 (fr) Acides acylamino-1 alcane-diphosphoniques-1,1 utilisables comme antitartres
BE816049A (fr) Derives d'acides benzodioxole-1
FR2325377A1 (fr) Nouveaux n-aryl-n- (1-l-4-piperidinyl)-arylacetamides
FR2298330A2 (fr) Nouveaux d
SE7609769L (sv) 1,2-bensisoxazolderivat
BE822933A (fr) Acides 7beta-acrylamidoceph-3-eme-4-carboxyliques
FR2319358A1 (fr) Nouveaux homophtalimides
IT1065963B (it) Ammidi n,n-disostituite di acidi omega-diaachilammi-noalcanoici
BE822124A (fr) Nouveaux hydroxyindanes 1
BE811821A (fr) Nouveaux acides perfluoroalkylalkylcarboxyliques
FR2316931A1 (fr) Derives d'acides dl- et 8 r-9-fluoro-prostadienoiques
BE832229A (fr) Acides 19, 20-bis-nor-prostanoiques hypolipemiants
BE828980A (fr) Acides 2,3-polymethylene-5-sulfamoylbenzoiques
BE846657A (fr) 2,4,6-triiodo-anilides 3,5-disubstitues d'acides polyhydroxy-monobasiques

Legal Events

Date Code Title Description
ST Notification of lapse